Journal of the Korean Chemical Society (대한화학회지)

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Design, Synthesis and Biological Evaluation of Some Novel Chalcones-sulphonamide Hybrids

  • Received : 2018.05.30
  • Accepted : 2018.07.09
  • Published : 2018.10.20
Download PDF
⟨ Previous Next ⟩

Abstract

A new class of Chalcone-Sulphonamide hybrids has been designed by condensing appropriate sulphonamide scaffold with substituted chalcones tethered by chloroacetyl chloride as a multi-target drug for therapeutic treatment. Chalcones were prepared by Claisen-Schmidt condensation of a substituted aldehyde with para aminoacetophenone. These Chalcone-Sulphonamide hybrids were screened by means of their antibacterial activity by NCCLS method. Among all these compounds, 5e and 5c displayed more potent growth inhibitory activity against Staphylococcus epidermidis and Pseudomonas aeruginosa bacteria respectively. Further, these hybrids were evaluated for their antifungal activity, among all hybrid 5a exhibited potent antifungal activity. The synthesized compounds were characterized by FT-IR, $^1HNMR$, $^{13}CNMR$ and HR-LCMS and spectral study supports the structures of synthesized Chalcone-Sulphonamide hybrids.

Keywords

References

  1. Colliste, C. B.; Bail, L.; Trouillas, P.; Pouget, C.; Habrioux, G.; et al. Chalcone structural requirements for antioxidant, estrogenic and antiproliferative activities. Anticancer Res. 2001, 21, 3949.
  2. Ngameni, B.; Kuete, V.; Ambassa, P.; Justine, K.; Marlyse, M. L; et al. Med. Chem. 2013, 3, 233.
  3. Chandrabose, K.; Narayana, S. K.; Narayana, M.; Sakhtivel, R.; Uma, V.; Elungavan, M.; Devrajan, K.; Piyush, T.; et al. Recent Pat. Anticancer Drug Discov. 2015, 10, 1.
  4. Chimenti, F.; Fioravanti, R.; Blasco, A.; Chimenti, P.; Secci, D.; Rossi, F.; et al. Chalcoes: A valid scaffold for mono amine oxidase inhibitors. J. Med. Chem. 2009, 52, 2818. https://doi.org/10.1021/jm801590u
  5. Kamal, A.; Prabhakar, S.; Ramaiah, M.; Venkat, R. P.; Ratna, R. C.; Malla, R. A.; Shankaraiha, N.; Lakshmi, N. R. T.; Pushpvalli, S.; Pal, B. M.; Eur. J. Med. Chem. 2011, 46, 3820. https://doi.org/10.1016/j.ejmech.2011.05.050
  6. Narender, T.; Venkateswarlu, K.; Vishnu, N. B.; Sarkar, S.; Tetrahedron Lett. 2011, 52, 5794. https://doi.org/10.1016/j.tetlet.2011.08.120
  7. Rajakumar, P.; Raja, S.; Tetrahedron Lett. 2008, 49, 6539. https://doi.org/10.1016/j.tetlet.2008.09.005
  8. Suvitha, S.; Siddig, I. A.; Mohammed, A. M.; Mohan, S.; Molecules 2012, 17, 6179. https://doi.org/10.3390/molecules17066179
  9. Ratchanok, P.; Amporn, S.; Prasit, M.; Chanin, N.; Supaluk, P.; Somsak, R.; Virapong, P. Eur. J. Med. Chem. 2014, 85, 65. https://doi.org/10.1016/j.ejmech.2014.07.087
  10. Iqbal, H.; Prabhakar, V.; Sangita, A.; Chandrika, B.; Balasubramanium, R. Med. Chem. Res. 2014, 23, 4383. https://doi.org/10.1007/s00044-014-1007-z
  11. Manik, D.; Kuntal, M. J. Toxicol. 2016, 1.
  12. Fathalla, O. A.; Zaghary, W. A.; Radwan, H. H.; Awad, S. M.; Mohamed, S. M. Arch. Pharm. Res. 2002, 23, 258.
  13. Van Leeuwen, R.; Katlama, C.; Kitchen, V.; et al. J. Infect. Dis. 1995, 171, 1166. https://doi.org/10.1093/infdis/171.5.1166
  14. Owa, T.; Nagasu, T. Expert Opin. Ther. Pat. 2000, 10, 1725. https://doi.org/10.1517/13543776.10.11.1725
  15. Sapuran, C. T.; Scozzafava, A.; Casini, A. Med. Res. Rev. 2003, 23, 146. https://doi.org/10.1002/med.10025
  16. Supuran, C. T.; Scozzafava, A. Immunol. Endocr. Metab. Agents Med. Chem. 2001, 1, 61. https://doi.org/10.2174/1568013013359131
  17. Maren, T. H. Annu. Rev. Pharmacol. Toxicol. 1976, 16, 309. https://doi.org/10.1146/annurev.pa.16.040176.001521
  18. Boyd, A. E. Diabetes 1988, 37, 847. https://doi.org/10.2337/diab.37.7.847
  19. Thornber C. W. Chem. Soc. Rev. 1997, 8, 563.
  20. Selvam, P.; Chandramohan, M.; De Clerk, E.; Witvrous, M.; Pannerouque, C. Eur. J. Pharm. Sci. 2001, 14, 313. https://doi.org/10.1016/S0928-0987(01)00197-X
  21. Park, K. H.; Lee, J. W.; Ryu, Y. B.; Ryu, H. W.; Lee, S. A. Method for screening anticancer compounds inhibiting function of TM4SF5 and anticancer composition containing chalcone compounds. 2014, CA2671987C.
  22. Chun, W. M.; Marzieh, Y.; Noorsaddah, A. R.; Kung, Y. B.; Pichika, M. R. Eur. J. Med. Chem. 2014, 77, 378. https://doi.org/10.1016/j.ejmech.2014.03.002
  23. Hamada, N. M. M.; Abdo, N. Y. M. Molecules 2015, 20, 10468. https://doi.org/10.3390/molecules200610468
  24. Asha, V. C.; Ratnadeep, S. J.; Priyanka, G. M.; Charansingh, H. G. J. Korean Chem. Soc. 2011, 55, 776. https://doi.org/10.5012/jkcs.2011.55.5.776